Circulating Levels of HMGB-1 and NPM/B23 proteins and Clinical Significance in Debut NSCLC patients
Tan Hui, Lu Liu, Ying Yi, Carmen Valenzuela, Qiang Zhao, Zhiwei Zhang, Wen Li, Silvio E. Perea, View ORCID ProfileYasser Perera
doi: https://doi.org/10.1101/2024.11.04.24316686
Tan Hui
1Cancer Research Institute of Hengyang Medical School, Key Laboratory of Cancer Cellular and Molecular Pathology in Hunan Province, University of South China, 28 Changsheng Road, Hengyang 421001, Hunan Province, China. People’s Republic of China
2Department of Pathology, The First Affiliated Hospital of University of South China, Hengyang, 421001, Hunan Province, China. People’s Republic of China
Lu Liu
2Department of Pathology, The First Affiliated Hospital of University of South China, Hengyang, 421001, Hunan Province, China. People’s Republic of China
Ying Yi
3China-Cuba Biotechnology Joint Innovation Center (CCBJIC), Yongzhou Development and Construction Investment Co., Ltd. (YDCI), Yangjiaqiao Street, Lengshuitan District, Yongzhou City, Hunan Province, 425000, China. People’s Republic of China
Carmen Valenzuela
4Institute of Cybernetics, Mathematics and Physics, Havana, Cuba, Calle 15 entre Cy D. Plaza de la Revolución. CP 10400; La Habana, Cuba
Qiang Zhao
2Department of Pathology, The First Affiliated Hospital of University of South China, Hengyang, 421001, Hunan Province, China. People’s Republic of China
Zhiwei Zhang
1Cancer Research Institute of Hengyang Medical School, Key Laboratory of Cancer Cellular and Molecular Pathology in Hunan Province, University of South China, 28 Changsheng Road, Hengyang 421001, Hunan Province, China. People’s Republic of China
Wen Li
3China-Cuba Biotechnology Joint Innovation Center (CCBJIC), Yongzhou Development and Construction Investment Co., Ltd. (YDCI), Yangjiaqiao Street, Lengshuitan District, Yongzhou City, Hunan Province, 425000, China. People’s Republic of China
Silvio E. Perea
5Molecular Oncology Group, Department of Pharmaceuticals, Biomedical Research Division, Center for Genetic Engineering & Biotechnology (CIGB), Havana 10600, Cuba
Yasser Perera
3China-Cuba Biotechnology Joint Innovation Center (CCBJIC), Yongzhou Development and Construction Investment Co., Ltd. (YDCI), Yangjiaqiao Street, Lengshuitan District, Yongzhou City, Hunan Province, 425000, China. People’s Republic of China
5Molecular Oncology Group, Department of Pharmaceuticals, Biomedical Research Division, Center for Genetic Engineering & Biotechnology (CIGB), Havana 10600, Cuba
Data Availability
All data produced in the present work are contained in the manuscript
Posted November 04, 2024.
Circulating Levels of HMGB-1 and NPM/B23 proteins and Clinical Significance in Debut NSCLC patients
Tan Hui, Lu Liu, Ying Yi, Carmen Valenzuela, Qiang Zhao, Zhiwei Zhang, Wen Li, Silvio E. Perea, Yasser Perera
medRxiv 2024.11.04.24316686; doi: https://doi.org/10.1101/2024.11.04.24316686
Subject Area
Subject Areas
- Addiction Medicine (398)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2911)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12693)
- Forensic Medicine (10)
- Gastroenterology (825)
- Genetic and Genomic Medicine (4554)
- Geriatric Medicine (413)
- Health Economics (724)
- Health Informatics (2903)
- Health Policy (1067)
- Hematology (384)
- HIV/AIDS (920)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4321)
- Nursing (233)
- Nutrition (634)
- Oncology (2255)
- Ophthalmology (642)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (277)
- Palliative Medicine (83)
- Pathology (496)
- Pediatrics (1194)
- Primary Care Research (493)
- Public and Global Health (6903)
- Radiology and Imaging (1521)
- Respiratory Medicine (913)
- Rheumatology (435)
- Sports Medicine (381)
- Surgery (483)
- Toxicology (60)
- Transplantation (209)
- Urology (178)